Patents-Review.com
ClassID:

97129 ⎘

C07K16/1228 - CPC Classification

Classification description:

Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia

Sub-classes:
Recent Application in this class:
#1
20250368723
2025-12-04

ANTI-O2 ANTIBODIES AND USES THEREOF

 #2
20250340620
2025-11-06

HYPERIMMUNIZED EGG PRODUCT FOR TREATING OR PREVENTING ALCOHOLIC LIVER DISEASE AND GRAFT-VERSUS-HOST DISEASE

 #3
20250304662
2025-10-02

FIMH INHIBITING COMPOSITIONS AND METHODS OF USE THEREOF

 #4
20250277016
2025-09-04

ANTIBODIES AND METHODS OF USE

 #5
20240383969
2024-11-21

ANTI-O1 ANTIBODIES AND USES THEREOF

 #6
20240294616
2024-09-05

CAMELIDAE SINGLE-DOMAIN ANTIBODIES AGAINST YERSINIA PESTIS AND METHODS OF USE

 #7
20240199723
2024-06-20

HYPERIMMUNIZED EGG PRODUCT FOR TREATING OR PREVENTING ALCOHOLIC LIVER DISEASE AND GRAFT-VERSUS-HOST DISEASE

 #8
20240069022
2024-02-29

METHOD AND KIT FOR DETECTING PRESENCE AND/OR AMOUNT OF BACTERIA OF ENTEROBACTERIACEAE IN FOOD/DRINK SAMPLE, ENVIRONMENTAL SAMPLE, OR BIOLOGICAL SAMPLE

 #9
20230220055
2023-07-13

ANTIBODIES TARGETING A GALACTAN-BASED O-ANTIGEN OF K. PNEUMONIAE

 #10
20230079661
2023-03-16

Anti-O2 antibodies and uses thereof

 #11
20230077855
2023-03-16

Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM

 #12
20220267418
2022-08-25

ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOF

 #13
20220259294
2022-08-18

Binding moieties for biofilm remediation

 #14
20220227846
2022-07-21

Eradication of bacterial biofilm using anti-amyloid monoclonal antibodies

 #15
20220056113
2022-02-24

Anti-O1 antibodies and uses thereof

 #16
20210347885
2021-11-11

SYNTHETIC BINDING AGENTS FOR LIMITING PERMEATION THROUGH MUCUS

 #17
20210332113
2021-10-28

METHODS OF SCREENING ANTIBODIES FOR TREATING AND/OR PREVENTING NECROTIZING ENTEROCOLITIS (NEC)

 #18
20210238263
2021-08-05

Anti-O2 antibodies and uses thereof

 #19
20210147518
2021-05-20

Camelidae single-domain antibodies against and methods of use

 #20
20210147517
2021-05-20

Camelidae single-domain antibodies against and methods of use

 #21
20210147516
2021-05-20

single-domain antibodies against and methods of use

 #22
20210147515
2021-05-20

Camelidae single-domain antibodies against and methods of use

 #23
20210139566
2021-05-13

single-domain antibodies against and methods of use

 #24
20210139565
2021-05-13

CAMELIDAE SINGLE-DOMAIN ANTIBODIES AGAINST YERSINIA PESTIS AND METHODS OF USE

 #25
20210122809
2021-04-29

Eradication of bacterial biofilm using anti-amyloid monoclonal antibodies

 #26
20200339668
2020-10-29

KLEBSIELLA PNEUMONIAE O3 SPECIFIC ANTIBODIES

 #27
20200237912
2020-07-30

METHOD FOR THE TREATMENT OR PREVENTION OF INFECTION-RELATED IMMUNE CONDITIONS USING A COMPOSITION COMPRISING IGM

 #28
20200231660
2020-07-23

Anti-O1 antibodies and uses thereof

 #29
20200190170
2020-06-18

Binding moieties for biofilm remediation

 #30
20200181601
2020-06-11

OB-fold used as scaffold for engineering new specific binders

 #31
20190358325
2019-11-28

Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM

 #32
20190225675
2019-07-25

Methods, compositions and kits for treating a subject using a recombinant neutralizing binding protein

 #33
20190161534
2019-05-30

ANTI-GALACTAN II MONOCLONAL ANTIBODIES TARGETING KLEBSIELLA PNEUMONIAE

 #34
20190153077
2019-05-23

O3 specific antibodies

 #35
20190062411
2019-02-28

MRKA POLYPEPTIDES, ANTIBODIES, AND USES THEREOF

 #36
20190055304
2019-02-21

Binding moieties for biofilm remediation

 #37
20180327461
2018-11-15

COMPOSITIONS AND METHODS FOR CONTROL OF VECTOR-BORNE DISEASE

 #38
20180312576
2018-11-01

ANTIBODIES TARGETING A MANNAN-BASED O-ANTIGEN OF K. PNEUMONIAE

 #39
20180298084
2018-10-18

BACTERICIDAL MONOCLONAL ANTIBODY TARGETING KLEBSIELLA PNEUMONIAE

 #40
20180066041
2018-03-08

Antibodies targeting a galactan-based O-antigen of K. pneumoniae

 #41
20180037637
2018-02-08

Probiotics, secretory IgA and inflammation

 #42
20180009906
2018-01-11

METHOD FOR PRODUCING MONOCLONAL IgA ANTIBODY

 #43
20170233496
2017-08-17

Affinity proteins and uses thereof

 #44
20170166887
2017-06-15

OB-fold used as scaffold for engineering new specific binders

 #45
20170129942
2017-05-11

Antibody molecule-drug conjugates and uses thereof

 #46
20170087239
2017-03-30

Polypeptides derived from and their use for vaccination and the generation of therapeutic antibodies

 #47
20170073397
2017-03-16

MrkA Polypeptides, Antibodies, and Uses Thereof

 #48
20170056497
2017-03-02

Method of treating protozoal gastrointestinal disorders in immunocompromised patients

 #49
20170035882
2017-02-09

Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM

 #50
20160368972
2016-12-22

Methods, compositions and kits for treating a subject using a recombinant neutralizing binding protein

 #51
20160237145
2016-08-18

Binding moieties for biofilm remediation

 #52
20160228527
2016-08-11

spp. polypeptides and methods of use

 #53
20160136285
2016-05-19

AN ISOLATED IMMUNOGENIC BACTERIAL ANTIGEN AND ITS USE IN THE PREVENTION AND TREATMENT OF INFECTIONS CAUSED BY GRAM-NEGATIVE BACTERIA

 #54
20160039944
2016-02-11

Method for producing monoclonal IgA antibody

 #55
20160031971
2016-02-04

Methods and compositions with a recombinant neutralizing binding protein for treating toxin exposure

 #56
20160010083
2016-01-14

OB-fold used as scaffold for engineering new specific binders

 #57
20150307598
2015-10-29

spp. polypeptides and methods of use

 #58
20150299298
2015-10-22

BINDING MOIETIES FOR BIOFILM REMEDIATION

 #59
20150197558
2015-07-16

BINDING MOIETIES FOR BIOFILM REMEDIATION

 #60
20150139998
2015-05-21

Cell wall polymers of and uses thereof

 #61
20150086561
2015-03-26

BINDING MOIETIES FOR BIOFILM REMEDIATION

 #62
20150050282
2015-02-19

Glycoconjugates and use thereof as vaccine against serotype 3a and X

 #63
20140294826
2014-10-02

Methods and compositions with a recombinant neutralizing binding protein for treating toxin exposure

 #64
20140170164
2014-06-19

spp. polypeptides and methods of use

 #65
20140161838
2014-06-12

spp. polypeptides and methods of use

 #66
20140161834
2014-06-12

spp. polypeptides and methods of use

 #67
20140161793
2014-06-12

Glycoconjugates and their use as potential vaccines against infection by

#68
20140017258
2014-01-16

Compositions against bacterial toxins

 #69
20130243751
2013-09-19

GLYCOCONJUGATES AND THEIR USE AS POTENTIAL VACCINES AGAINST INFECTION BY SHIGELLA FLEXNERI

 #70
20130230526
2013-09-05

KLEBSIELLA ANTIGENS

 #71
20130011403
2013-01-10

antigens

 #72
20120121638
2012-05-17

Polypeptide derived from and its use for vaccination

 #73
20120114656
2012-05-10

Human monoclonal antibodies protective against bubonic plague

 #74
20120064572
2012-03-15

Bacterial virulence factors and uses thereof

 #75
20110268743
2011-11-03

Probiotics, secretory IgA and inflammation

 #76
20110236410
2011-09-29

antigens

 #77
20110206674
2011-08-25

Yersinia SPP. Polypeptides and Methods of Use

 #78
20100239584
2010-09-23

Glycoconjugates and use thereof as vaccine against serotype 3a and X

 #79
20100145008
2010-06-10

OB-FOLD USED AS SCAFFOLD FOR ENGINEERING NEW SPECIFIC BINDERS

 #80
20090324723
2009-12-31

Method of prophylaxis of infection

 #81
20090104232
2009-04-23

Compositions and methods for inhibiting infection

 #82
20080286779
2008-11-20

Host Cells Containing Multiple Integrating Vectors

 #83
20080112951
2008-05-15

Glycoconjugates and their use as potential vaccines against infection by

#84
20080025999
2008-01-31

Yersinia species compositions

 #85
20070292426
2007-12-20

Methods and compositions based on Shiga toxin type 1 protein

 #86
20070041997
2007-02-22

Bacterial virulence factors and uses thereof

 #87
20060280759
2006-12-14

Live and subunit vaccines

 #88
20060269564
2006-11-30

spp. polypeptides and methods of use

 #89
20060246084
2006-11-02

Yersinia polypeptide vaccines, antibodies and immunomodulatory proteins

 #90
20060134101
2006-06-22

Use of avian antibodies

 #91
20060093609
2006-05-04

Vaccine against comprising one or two antibodies, one specific for F1-antigen and the other one for V-antigen

 #92
20050244425
2005-11-03

Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability

 #93
20050241023
2005-10-27

Transgenic plants expressing assembled secretory antibodies

 #94
20050232940
2005-10-20

Recombinant plasmid and a method of controlling the effects of yersinia pestis

 #95
20050220894
2005-10-06

Colostrum-based composition

 #96
20050220797
2005-10-06

Prophylactic and therapeutic monoclonal antibodies

 #97
20050100952
2005-05-12

Host cells containing multiple integrating vectors

 #98
20050060762
2005-03-17

Expression vectors

 #99
17033516
2023-07-18

Synthetic anti-plague antibodies

 #100
16023723
2022-05-24

Camelidae single-domain antibodies against and methods of use